Empowered Funds LLC decreased its position in Colgate-Palmolive (NYSE:CL – Free Report) by 8.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,951 shares of the company’s stock after selling 5,651 shares during the period. Empowered Funds LLC’s holdings in Colgate-Palmolive were worth $5,814,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the company. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive in the fourth quarter worth approximately $32,000. Hager Investment Management Services LLC purchased a new position in Colgate-Palmolive in the 4th quarter worth approximately $36,000. Reston Wealth Management LLC bought a new position in Colgate-Palmolive in the 3rd quarter valued at approximately $42,000. Synergy Asset Management LLC purchased a new stake in Colgate-Palmolive during the 4th quarter valued at $49,000. Finally, Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive in the 3rd quarter worth $53,000. 80.41% of the stock is owned by hedge funds and other institutional investors.
Colgate-Palmolive Stock Performance
CL opened at $87.35 on Wednesday. The firm has a market cap of $71.37 billion, a P/E ratio of 24.82, a PEG ratio of 4.12 and a beta of 0.44. Colgate-Palmolive has a 1-year low of $82.68 and a 1-year high of $109.30. The company has a 50 day simple moving average of $90.14 and a two-hundred day simple moving average of $96.69. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26.
Colgate-Palmolive Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.29%. Colgate-Palmolive’s payout ratio is 56.82%.
Analyst Ratings Changes
Several research firms recently commented on CL. Raymond James reaffirmed an “outperform” rating and set a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. UBS Group reduced their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Royal Bank of Canada restated a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Finally, Piper Sandler lowered their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive has a consensus rating of “Hold” and an average target price of $101.16.
Check Out Our Latest Stock Analysis on CL
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Best Aerospace Stocks Investing
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- How to Invest in Blue Chip Stocks
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.